Search - tctmd.com

Displaying 341 - 360 of 763

Sort: Relevancy | Date

Presentation TCT 2017

RAPID Program: Industry View

Presenter: Schuyler Jones, Hiroyoshi Yokoi, Robert Thatcher

October 30, 2017

Presentation TCT 2017

Uses and Outcomes of the MitraClip in The US: Updated STS Registry Results

Presenter: James B. Hermiller Jr., Ralph Stephan von Bardeleben, Paul Sorajja

October 30, 2017

Presentation TCT 2017

WATCHMAN: Data Synthesis and Ongoing Trials

Presenter: William A. Gray, Vivek Y. Reddy

October 30, 2017

Presentation TCT 2017

RAPID Program: Academic View

Presenter: Schuyler Jones, Hiroyoshi Yokoi

October 30, 2017

Presentation TCT 2017

RAPID Program: PMDA View

Presenter: Schuyler Jones, Hiroyoshi Yokoi, Yoshimasa Yokoyama

October 30, 2017

Presentation TCT 2017

Do the PIONEER and RE-DUAL Results Alter LAA Closure Decisions?

Presenter: William A. Gray, Vivek Y. Reddy, C. Michael Gibson

October 30, 2017

Presentation TCT 2017

Registry Assessment of Peripheral Interventional Devices (RAPID) Program

Presenter: Schuyler Jones, Hiroyoshi Yokoi, Eleni Whatley

October 30, 2017

Presentation TCT 2017

BioNIR: Specifications and BIONICS/NIREUS Results in Perspective

Presenter: Stephen G. Ellis, David E. Kandzari

October 30, 2017

Presentation TCT 2017

Should the Improved Results With NOACs Compared to Warfarin Change LAA Closure Decisions?

Presenter: William A. Gray, Vivek Y. Reddy, Kurt Huber

October 30, 2017

Presentation TCT 2017

Resolute and Onyx Zotarolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective

Presenter: Stephen G. Ellis, David E. Kandzari, Matthew J. Price

October 30, 2017

Presentation TCT 2017

Promus Element Everolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective

Presenter: Stephen G. Ellis, David E. Kandzari, Sigmund Silber

October 30, 2017

Presentation TCT 2017

XIENCE Everolimus-Eluting Stents: Device Iterations, Randomized/Registry Outcomes Data in Perspective and the Move to Shorter DAPT

Presenter: Stephen G. Ellis, David E. Kandzari, Tullio Palmerini

October 30, 2017

Presentation TCT 2017

How to Optimize Intraluminal Antegrade Crossing for Infrainguinal CTOs: Dedicated Wires and Re-entry Devices

Presenter: Ehrin J. Armstrong, Sahil A. Parikh, Steve Henao

October 30, 2017

Presentation TCT 2017

The Landscape of CV Device Innovation for Children: Regulatory View

Presenter: Nicole Ibrahim, Satoshi Yasukochi, Sara Takahashi

October 30, 2017

Presentation TCT 2017

FDA Perspectives: Diversity in Clinical Trials and its Impact of Device Evaluation

Presenter: Wayne B. Batchelor, George A. Mensah, Christopher J Popma

October 30, 2017

Presentation TCT 2017

Bifurcation Stents 1: TRYTON Description, Data, and Case Examples

Presenter: Alaide Chieffo, Jeffrey W. Moses, Philippe Genereux

October 30, 2017

Presentation TCT 2017

The Landscape of CV Device Innovation for Children: Regulatory View

Presenter: Nicole Ibrahim, Satoshi Yasukochi, Nicole Milligan

October 30, 2017

Presentation TCT 2017

Bifurcation Stents 4: NILE Description, Data, and Case Examples

Presenter: Alaide Chieffo, Jeffrey W. Moses, Ivo Petrov

October 30, 2017

Presentation TCT 2017

The Landscape of CV Device Innovation for Children: Industry View

Presenter: Nicole Ibrahim, Satoshi Yasukochi, Lisa Becker

October 30, 2017

Presentation TCT 2017

Bifurcation Stents 3: BIOSS Description, Data, and Case Examples

Presenter: Alaide Chieffo, Jeffrey W. Moses, Ricardo A. Costa

October 30, 2017

Advertisement

RAPID Program: Industry View

Uses and Outcomes of the MitraClip in The US: Updated STS Registry Results

WATCHMAN: Data Synthesis and Ongoing Trials

RAPID Program: Academic View

RAPID Program: PMDA View

Do the PIONEER and RE-DUAL Results Alter LAA Closure Decisions?

Registry Assessment of Peripheral Interventional Devices (RAPID) Program

BioNIR: Specifications and BIONICS/NIREUS Results in Perspective

Should the Improved Results With NOACs Compared to Warfarin Change LAA Closure Decisions?

Resolute and Onyx Zotarolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective

Promus Element Everolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective

XIENCE Everolimus-Eluting Stents: Device Iterations, Randomized/Registry Outcomes Data in Perspective and the Move to Shorter DAPT

How to Optimize Intraluminal Antegrade Crossing for Infrainguinal CTOs: Dedicated Wires and Re-entry Devices

The Landscape of CV Device Innovation for Children: Regulatory View

FDA Perspectives: Diversity in Clinical Trials and its Impact of Device Evaluation

Bifurcation Stents 1: TRYTON Description, Data, and Case Examples

The Landscape of CV Device Innovation for Children: Regulatory View

Bifurcation Stents 4: NILE Description, Data, and Case Examples

The Landscape of CV Device Innovation for Children: Industry View

Bifurcation Stents 3: BIOSS Description, Data, and Case Examples

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content